PharmaLogic
- Biotech or pharma, therapeutic R&D
PharmaLogic is a leading global contract development and manufacturing organization (CDMO) specializing in diagnostic and therapeutic radiopharmaceuticals. With decades of industry expertise and a network of 45+ facilities across the U.S., Puerto Rico, Canada, and Norway, PharmaLogic delivers comprehensive solutions spanning development, manufacturing, and distribution of clinical and commercial-stage radiopharmaceuticals—meeting the highest quality and regulatory standards. Our expanding diagnostics business leverages advanced technologies to improve access to novel imaging agents in oncology, cardiology, and Alzheimer’s disease. In therapeutics, PharmaLogic is the world’s only cGMP-compliant CDMO manufacturing and distributing a commercial radiopharmaceutical therapy to over 30 countries. We are committed to global patient access through strategic partnerships that advance the field and support the full product lifecycle.